By Stephen Bouvier2021-05-10T15:27:00+01:00
A trio of lawmakers in the upper house of the United Kingdom parliament have lined up to launch an unprecedented attack on accounting policy issues.
In the firing line was the new body charged with endorsing International Financial Reporting Standards for use in the UK, the International Accounting Standards Board’s planned new insurance liabilities accounting standard, IFRS 17, and the mark-to-market pensions model.
Long-standing IFRS critic Lord Prem Sikka said: “In common with the Financial Reporting Council, the newly created Accounting Standards Endorsement Board will primarily rubber-stamp the international accounting standards, better known as the international financial reporting standards, or IFRS.”
Luxembourg, May 6, 2021 - ArcelorMittal (referred to as "ArcelorMittal" or the "Company") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company
SASB develops new ESG standards as the SEC calls for better disclosure accountingtoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from accountingtoday.com Daily Mail and Mail on Sunday newspapers.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 15 US clinical centers
Five partnered allogeneic CAR-T product candidates in clinical development through our collaborations with Allogene and Servier: UCART19/ALLO-501 and ALLO-501A in r/r NHL, ALLO-715 and ALLO-605 in r/r MM and ALLO-316 in advanced or metastatic clear cell renal cell carcinoma
New collaboration with Cytovia Therapeutics, Inc. to develop TALEN
®
Successful for UCART product candidates; On track to start production of UCART product candidates in 2021
Canadian Natural Resources Limited Announces 2021 First Quarter Results
Commenting on the Company’s first quarter 2021 results, Tim McKay, President of Canadian Natural stated “The COVID-19 pandemic continues to challenge our everyday living and the way we operate our businesses. With our strong measures in place we have minimized impacts on our operations, but it remains a daily challenge for our field staff to do it safe and do it right. As the global vaccine distribution increases …
Commenting on the Company’s first quarter 2021 results, Tim McKay, President of Canadian Natural stated “The COVID-19 pandemic continues to challenge our everyday living and the way we operate our businesses. With our strong measures in place we have minimized impacts on our operations, but it remains a daily challenge for our field staff to do it safe and do it right. As the global vaccine distribution increases and crude oil demand recovers, especially in the United States, we are seeing